Senators Press DOJ Watchdog to Scrutinize Genesis Bankruptcy Sale as Auction Nears

Washington, DC — Sen. Richard Blumenthal is urging the Justice Department’s bankruptcy watchdog to step in as Genesis HealthCare’s court-supervised auction approaches, warning that the fast-track sale could shield insiders and erase billions in claims tied to resident harm.

In a Nov. 10 letter to U.S. Trustee William K. Harrington, Blumenthal (D-Conn.) asked the agency to closely review Genesis’s Chapter 11 process and potential insider bidding. Sen. Elizabeth Warren (D-Mass.) co-signed the request. The lawmakers say the plan risks wiping out roughly $1.6 billion in patient liability claims while allowing executives and private investors to retain control.

Senators press watchdog over insider concerns

Blumenthal called the proposed sale an attempt to “abuse the bankruptcy system to shield private equity looters from accountability,” according to his letter. Warren, in a separate statement, criticized what she described as a pattern of profits over care tied to Genesis’s financial backers.

Genesis, one of the nation’s largest nursing home operators, sought Chapter 11 protection in July 2025 with about $1.2 billion in debt, citing inflation, staffing costs and a heavy lease burden, according to court filings. The company operates roughly 410 skilled nursing facilities and 60 assisted living communities across 25 states, serving about 50,000 residents.

A fast-track sale under scrutiny

Filings show Genesis is seeking court approval for an expedited auction in the U.S. Bankruptcy Court for the District of Delaware, with a hearing on bid procedures set for Nov. 18. Industry sources say an affiliate of Omega Healthcare Investors, ReGen Healthcare, is positioned as the likely stalking-horse bidder and has provided $30 million in debtor-in-possession financing to fund operations during the case.

Lawmakers and advocates argue the current structure could favor insiders and leave families with little recourse. More than 100 negligence and wrongful death lawsuits have been stayed under bankruptcy protections, court records indicate. A federal judge allowed those pauses to continue in October to prevent disruptions to the sale timeline.

What’s at stake for residents

Critics say Genesis’s planned restructuring would remove sizable legal liabilities tied to allegations of neglect and pandemic-era failures without addressing deeper quality issues. Warren has pointed to federal disclosures showing Genesis received hundreds of millions in COVID relief funds as resident deaths mounted, while executives collected bonuses. Between 2020 and 2024, Genesis executives received about $28 million in bonuses, according to documents cited by the lawmakers.

Genesis counters that the Chapter 11 process is aimed at stabilizing operations and protecting residents. “Our Chapter 11 process is designed to stabilize operations and ensure seamless care continuity for 50,000 residents,” a company spokesperson said in a statement this month. The company says a timely sale will reduce debt and avoid facility closures.

Broader industry implications

The scrutiny arrives as nursing homes nationwide wrestle with elevated labor costs and thin margins. Advocates argue private equity ownership has added pressure to cut expenses, sometimes at the expense of care. A 2021 study in JAMA linked private equity-owned nursing homes with worse outcomes, including higher mortality, though industry groups counter that chronic Medicaid underfunding is the primary driver of instability.

Consumer advocates warn that rushed restructuring can obscure accountability for past harms and leave residents vulnerable if operators change hands without clear quality safeguards. Provider groups, meanwhile, say court oversight and fresh capital are necessary to keep doors open and preserve access to care, especially in rural markets.

What’s next

The Delaware court will consider Genesis’s proposed bidding rules on Nov. 18, with an auction expected in late November or early December if approved, according to filings. The U.S. Trustee could ask the court to slow the timeline, appoint an independent examiner, or modify bid protections if it finds the process unfair, bankruptcy experts say.

For families and staff across Genesis’s 25-state footprint, the outcome will determine not just who owns the facilities, but how potential claims are handled — and whether the restructuring fixes systemic problems that predated the bankruptcy.